Donald Robert Schemel insider trades: Sun BioPharma (SNBP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Donald reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 14, 2016 | SNBP | ↓ Sell | 7,000 | $1.43 | $10K | By Spouse | Dec 1, 2016 (17d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Donald Robert Schemel's insider trades
Donald Robert Schemel is a director at Sun BioPharma (SNBP). Since Nov 14, 2016, Donald has reported no open-market purchases and 1 sale worth $10K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), other transactions (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNBP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.